Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May

Abstract

Introduction

This study aims to evaluate the primary patency and clinical outcomes after stenting for residual iliac venous stenosis during catheter-directed thrombolysis treatment of acute iliofemoral deep vein thrombosis arising from May–Thurner syndome.

Methods

A retrospective study was done for the all patients who underwent iliac vein stenting after catheter-directed thrombolysis treatment of acute iliofemoral deep vein thrombosis due to May–Thurner syndrome from January 2005 to April 2011 in Inha University Hospital. Patient information was assembled from the electronic medical records, imaging and interview. The patency of iliac vein stent was evaluated with serial computed tomography.

Results

Fifty-one patients were enrolled. The median age was 70 years (range 44–86). There were 37 females (72.5%). The duration of symptoms of acute deep vein thrombosis before catheter-directed thrombolysis treatment was 6 days (median, range 1–33). Self-expanding stent was used for iliac vein stenting. Initial technical success rate was 94.1%. There were two complications (3.9%): an arteriovenous fistula formation in left popliteal area and a right inguinal hematoma. Mean follow-up was 15.6 months (range 6 days–80.8 months). Primary patency rate after iliac vein stenting was 95.8% at 6 months, 87.5% at 12 months and 84.3% at 24 months. Four patients had recurrent thrombotic occlusion (7.8%) during the follow-up.

Conclusion

Iliac vein stenting showed good primary patency rate with few complications. Iliac vein stenting is a durable option for residual stenosis after catheter-directed thrombolysis treatment of acute deep vein thrombosis in May–Thurner syndrome.

Keywords

Deep vein thrombosis iliac veins May–Thurner syndrome stent

Get full access to this article

View all access options for this article.

References

May

Thurner

. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957; 8: 419–427.

Kim

Choi

Guk

. Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome. Cardiovasc Interven Radiol 2006; 4: 571–575.

Hartung

Benmiloud

Barthelemy

. Late results of surgical venous thrombectomy with iliocaval stenting. J Vasc Surg 2008; 47: 381–387.

Jeon

Chung

Jae

. May-Thurner syndrome complicated by acute iliofemoral vein thrombosis: helical CT venography for evaluation of long-term stent patency and changes in the iliac vein. Am J Roentgenol 2010; 195: 751–757.

Titus

Moise

Bena

. Iliofemoral stenting for venous occlusive disease. J Vasc Surg 2011; 53: 706–712.

Berger

Jaffe

York

. Iliac compression syndrome treated with stent placement. J Vasc Surg 1995; 21: 510–514.

May

Thurner

. Ein gefassporn in der vena iliaca communis sinistra als wahrscheinliche Ursache der uberwiegende linksseitigen beckenvenenthrombose. Z Kreisl-Forsch 1956; 45: 912–922.

Baron

Sharms

Wayne

. Iliac vein compression syndrome: a new method of treatment. Am Surg 2000; 66: 653–655.

Nazarian

Bjarnason

Dietz

. Iliofemoral venous stenosis: effectiveness of treatment with metallic endovascular stents. Radiology 1996; 200: 193–199.

10.

Patel

Stookey

Ketcham

. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interven Radiol 2000; 11: 1297–1302.

11.

Messina

Sarpa

Smith

. Clinical significance of routine imaging of iliac and calf veins by color flow duplex scanning in patients suspected of having acute lower extremity deep venous thrombosis. Surgery 1993; 114: 921–927.

12.

Baglin

Brush

Streiff

. Guidelines on use of vena cava filters. Br J Haematomogy 2006; 134: 590–595.

13.

Initial communication FDA. Safety alerts for human medical products inferior vena cava (IVC) filters: initial communication: risk of adverse events with long term use. FDA, 2010.

14.

Carrier

Rodger

Wells

. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost 2011; 9: 1119–1125.

15.

Hölper

Kotelis

Attigah

. Long term results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010; 39: 349–355.

16.

Husmann

Heller

Kalka

. Stenting of common iliac vein obstructions combined with regional thrombolysis and thrombectomy in acute deep vein thrombosis. Eur J Vasc Endovasc Surg 2007; 34: 87–91.

17.

Kwak

Han

Lee

. Stent in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interven Radiol 2005; 16: 1120–1120.

18.

Mullens

De Keyser

Van Dorpe

. Migration of two venous stents into the right ventricle in a patient with May-Thurner syndrome. Int J Cardiol 2006; 110: 114–115.

19.

Jackson L, Wang X, Dudrick S, et al. Catheter directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis. Am J Surg. 2005; 190: 864–868.

20.

Knipp BS, Ferguson E, Williams DM, et al. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg. 2007; 46: 743–749.

21.

Oguzkurt L, Tercan F, Ozkan U, et al. Iliac vein compression syndrome: outcome of endovascular treatment with long-term follow-up. Eur J Radiol 2008; 68: 487–492.

22.

Kölbel T, Lindh M, Akesson M, et al. Chronic iliac vein occlusion: midterm results of endovascular recanalization. J Endovasc Ther 2009; 16: 483–491.

23.

Baekgaard N, Broholm R, Just S, et al. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010; 39: 112–117.

24.

Jeon UB, Chung JW, Jae HJ, et al. May-Thurner syndrome complicated by acute iliofemoral vein thrombosis: helical CT venography for evaluation of long-term stent patency and changes in the iliac vein. AJR Am J Roentgenol 2010; 195: 751–757.

25.

Titus JM, Moise MA, Bena J, et al. Iliofemoral stenting for venous occlusive disease. J Vasc Surg 2011; 53: 706–712.

26.

Kurklinsky AK, Bjarnason H, Friese JL, et al. Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol 2012; 23: 1009–1015.

Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May–Thurner syndrome